Croda International
CRDA: 3,109.11 -108.00 (▼3.38%)
| Bid Price | 3,083.00 | High Price | 3,197.00 |
|---|---|---|---|
| Ask Price | 3,085.00 | Low Price | 3,076.00 |
| Open Price | 3,189.00 | Spread | 0.06% |
| Prev Close | 3,084.00 | Volume | 491,765.00 |
Croda International Share Price Chart
Intraday
Historic – 1 year
Croda International Share Price Information
| Name | Croda International | Epic | CRDA |
|---|---|---|---|
| Sector | Chemicals | ISIN | GB00BYZWX769 |
| Activites | Croda is a world leader in natural based speciality chemicals which are sold to virtually every type of industry. The company has approximately 3400 employees, working in 34 countries. Activities can be broadly classified into three sectors: Consumer Care which consists of global businesses in personal care, health care and crop care – all markets with an increasing need for innovation and sustainable ingredients. Performance Technologies which comprises home care, additives for polymers, polymers and coatings, lubricant additives, and processed vegetable oils. Industrial Chemicals which consists of base oleochemicals. In addition, the group has an Enterprise Technology function which identifies and integrates new technology into Croda’s global business structure. | Security Type | Equity |
Key numbers
| Latest Share Price (p) | 3,084.00 | Net Gearing (%) | 47.79 |
|---|---|---|---|
| Market Cap (£m) | 4,153.99 | Gross Gearing (%) | 52.32 |
| Shares in issue (m) | 131.25 | Debt Ratio | 42.74 |
| P/E Ratio | 23.74 | Debt-to-Equity Ratio | 0.68 |
| Divs per share (p) | 69.00 | Assets / Equity Ratio | 2.10 |
| Dividend Yield (%) | 2.24 | Price to book value | 6.84 |
| Dividend Cover | 2.02 | SROCE (%) | 23.79 |
| Earning per share (p) | 133.30 | EPS Growth (%) | 9.35 |
| 52-week high / low (p) | 3,778.50 / 2,635.00 | DPS Growth (%) | 5.34 |
Croda International Broker Views
| Date | Broker | Rec. | Price | Old target price | New target price | Notes |
|---|---|---|---|---|---|---|
| 30 Nov | Deutsche Bank | Buy | 3,109.11 | 3600.00 | 3300.00 | Downgrades |
| 21 Nov | Goldman Sachs | Neutral | 3,109.11 | 3325.00 | Initiates/Starts | |
| 15 Nov | Exane BNP Paribas | Underperform | 3,109.11 | 3000.00 | 3000.00 | Reiterates |
| 07 Nov | Numis | Hold | 3,109.11 | 3419.00 | 3419.00 | Reiterates |
| 03 Nov | Liberum Capital | Hold | 3,109.11 | 3500.00 | 3500.00 | Reiterates |
Croda International Director Deals
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 01 Nov 2016 | Steve Foots | Exercise | 223 @ 2141.00p | £4,774.43 |
| 05 Oct 2016 | Steve Williams | Dividend Reinvestment | 102 @ 3609.60p | £3,681.79 |
| 13 Sep 2016 | Jez Maiden | Buy | 4 @ 3264.00p | £130.56 |
| 13 Sep 2016 | Keith Layden | Buy | 5 @ 3264.00p | £163.20 |
| 13 Sep 2016 | Steve Foots | Buy | 5 @ 3264.00p | £163.20 |
| 11 Aug 2016 | Jez Maiden | Buy | 5 @ 3370.00p | £168.50 |
| 11 Aug 2016 | Keith Layden | Buy | 4 @ 3370.00p | £134.80 |
| 11 Aug 2016 | Steve Foots | Buy | 4 @ 3370.00p | £134.80 |
Croda International Company News
Broker Forecast – Deutsche Bank issues a broker note on Croda International PLC
Deutsche Bank today downgrades its investment rating on Croda International PLC (LON:CRDA) to buy (from hold) and cut its price target to 3300p (from 3600p).
Story provided by StockMarketWire.com
Broker Forecast – Goldman Sachs issues a broker note on Croda International PLC
Goldman Sachs today initiates coverage of Croda International PLC (LON:CRDA) with a neutral investment rating and price target of 3325p.
Story provided by StockMarketWire.com
Croda reaffirms FY outlook
Croda International has reaffirmed its full-year outlook after continued profitable growth in the third quarter.
Constant currency sales increased by 2.5% in the quarter and by 2.4% in the year to date.
It says innovation continues to enhance the product portfolio, with New and Protected Products (‘NPP’) accounting for 27.6% of year to date sales (2015: 26.4%). The quarter also benefited from Incotec, the seed enhancement business acquired in December 2015.
Third quarter sales continued broadly in line with first half year trends and profit was in line with our expectations. Sales rose by 20.1% to £315.3 million (Q3 2015: £262.5m).
With over 95% of sales outside the UK, this largely reflected favourable currency translation, with the impact of weaker sterling increasing sales by 17.6%. Year to date sales increased by 11.7% to £924.0m (2015: £827.1 million), with a favourable currency translation impact of 9.3%. Underlying sales in the core business slowed slightly versus the second quarter, down 2.5% in the third quarter and 1.2% lower year to date, predominantly due to the adverse impact of lower pricing for its generic Omega 3 API.
Story provided by StockMarketWire.com
FLASH: Croda reaffirms FY outlook
Story provided by StockMarketWire.com
Broker Forecast – Berenberg issues a broker note on Croda International PLC
Berenberg today reaffirms its hold investment rating on Croda International PLC (LON:CRDA) and raised its price target to 3650p (from 3150p).
Story provided by StockMarketWire.com
